Insulet Corporation
$145.31
+1.4%Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
High confidenceValuation multiple is elevated (P/E 41.4).
Valuation inputs: P/E 41.4, earnings yield +2.4%, momentum +1.4%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is acceptable (ROE +16.3%, ROIC +13.6%).
Profitability stack: net margin +9.1%, ROE +16.3%, ROIC +13.6%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceDownside profile looks controlled across current risk inputs.
Risk factors: liabilities/assets +52.5%, momentum +1.4%, net margin +9.1%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Insulet Corporation Market vs Earnings Trajectory
Loading price and EPS data...
Insulet Corporation Fair Value Envelope
Insulet Corporation Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Healthy operating margins demonstrate effective cost control and strong business fundamentals.
Net Profit Margin
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Insulet Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
Insulet Corporation Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Insulet Corporation Street Expectations Map
Wall Street analysts project that PODD stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 227.00, with estimates ranging from a low of 198.00 to a high of 280.00.
The consensus 1-year price target stands at 227.00, with estimates ranging from a low of 198.00 to a high of 280.00.
Analyst Consensus Analysis
Upside Potential
Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.
Analyst Agreement
Good consensus alignment. Moderate target spread reflects general agreement on value drivers with some variance in assumptions.
Analyst Conviction
Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.
Market Sentiment Insight
Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.
Insulet Corporation Insider Positioning
During the last 12 months, insiders have purchased $1.83M and sold $4.14M worth of PODD shares, resulting in $2.31M of net selling activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
6.3K
1.53M
1.9K
542.51K
+987K
+$987K
6-9 Months
962
299.88K
1.5K
516.73K
-217K
-$217K
9-12 Months
0
0.00
9.7K
3.08M
-3.1M
-$3.08M
Top Buyers
Mcevoy Ashley
Director, Officer: President And Ceo
$1.03M
Minogue Michael R
Director
$500K
Stonesifer Timothy C.
Director
$300K
Top Sellers
Benjamin Eric
Officer: Evp, Cpxo
$1.42M
Singh Prem
Officer: Svp, Global Operations
$1.37M
Frederick Wayne A.I.
Director
$543K
Manea Dan
Officer: Svp, Chief Hr Officer
$390K
Cousin Laetitia
Officer: Svp, Reg, Quality & Compliance
$278K
Insider Activity Analysis
Net Insider Sentiment
Negative insider sentiment with $2.31M net selling. Selling notably exceeds buying, warranting closer scrutiny of company fundamentals.
Buy/Sell Ratio
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Insider Participation
5 insider sellers vs. 3 buyers. More insiders selling than buying suggests cautious or negative sentiment.
No Dividend Yield Data
PODD has not reported any dividend yield values in the available annual periods.
podd Dividend History
Learning Layer
Related Guides
Build conviction on PODD by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.